Endpoints News ٢ يونيو ٢٠٢٦ FDA details flexibilities for new cell and gene therapies to leverage past data
FierceBiotech ٢ يونيو ٢٠٢٦ ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer
GE HealthCare ٢ يونيو ٢٠٢٦ GE HealthCare to Showcase Latest Technologies, AI-enabled Workflows - Imaging Technology News
Roche Media ٢ يونيو ٢٠٢٦ ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer - Fierce Biotech
Harvard Bioscience ٢ يونيو ٢٠٢٦ Harvard Bioscience stock (US4169061052): Nasdaq-listed share extends early-June rebound - AD HOC NEWS
BioPharma Dive ٢ يونيو ٢٠٢٦ Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
Endpoints News ٢ يونيو ٢٠٢٦ What’s next for VEGF? #ASCO26 offered clues, but answers will have to wait
Thermo Fisher ٢ يونيو ٢٠٢٦ Mettler-Toledo International vs Thermo Fisher Scientific: Which Is the Stronger Buy Today? - Trefis
Merck & Co. ٢ يونيو ٢٠٢٦ Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances - Fierce Pharma
FierceBiotech ٢ يونيو ٢٠٢٦ Travere scales Everest with $1.1B deal for BTK inhibitor aimed at rare kidney diseases